| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |